ALS Patients May Benefit Most from Tailored Brain–Computer Interface Programs
Cognitive impairment may present an obstacle for patients with amyotrophic lateral sclerosis (ALS) using brain-computer interface devices, according to a…
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Cognitive impairment may present an obstacle for patients with amyotrophic lateral sclerosis (ALS) using brain-computer interface devices, according to a…
Researchers have, for the first time, managed to selectively alter gene expression in brain motor neurons of mice modeling amyotrophic…
Biopharmaceutical company Neuralstem presented new and potentially promising results from its clinical investigations of NSI-566 — human spinal cord-derived neural stem cells for…
A report from the Boston University School of Public Health shows that Gulf War Illness is a result of…
The U.S. Department of Defense announced that nine researchers are the winners of the 2015 ALS Research Program (ALSRP), which aims to improve…
Entrepreneur Kevin Gosnell announced the launch of ALS ONE – a partner organization of the ALS Association and ALS Finding…
The ratio of N-acetyl aspartate (NAA) to glutamate is related to disease duration in patients with amyotrophic lateral sclerosis (ALS), a…
A panel of leading amyotrophic lateral sclerosis (ALS) researchers recently published a review study, supported by the ALS Association,…
A report in the journal JAMA Neurology revealed positive findings from the first Phase 1/2 clinical trial and the…
University of Bern researchers have discovered that the synaptic protein Homer-3 is linked to the death of Purkinje motor neurons in Spinocerebellar…